Cimt denied due to quantity / dose limits by Cigna?
Quantity-limit denials usually flip when the appeal documents the clinically appropriate dose for the patient's weight, kidney function, or escalation schedule, citing the FDA label or specialty-society guideline.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What Cigna typically requires
Cigna's specific coverage criteria for cimt are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.
The Cigna angle on Cimt
## Why Cigna Limits the Quantity of CIMT Sessions — and Why You Can Appeal
Cigna's coverage policy for Constraint-Induced Movement Therapy (CIMT) may specify a maximum number of therapy sessions, treatment days, or total program hours that it considers medically necessary for a standard course of treatment. When the prescribing provider requests a program that exceeds those limits — or when a second course of CIMT is requested — Cigna may deny the additional sessions as exceeding quantity limits.
Quantity-limit denials for rehabilitation services are regularly overturned on appeal when clinical documentation establishes that the patient's functional deficit, recovery trajectory, or clinical circumstances justify the additional treatment. The key is demonstrating that the requested quantity is individually medically necessary for this patient, not that it deviates from a population average.
## Federal Appeal Rights
- Internal appeal (ERISA §503 / ACA): File within 180 days of denial. Cigna must respond within 60 days (30 days for pre-service).
- Concurrent review / expedited appeal: If sessions are ongoing and interruption poses clinical risk, request expedited review — response required within 72 hours.
- External review (ACA §2719): Available after internal exhaustion, within approximately 4 months of the final denial. External reviewers assess whether the quantity limit is consistent with generally accepted clinical standards for the patient's individual presentation.
## What to Gather
1. Progress documentation: Detailed therapy progress notes showing measurable functional improvement over the sessions already completed — evidence that the treatment is working and that continued treatment is expected to produce further gains. 2. Remaining functional deficit: Current standardized assessment of upper-limb motor function, demonstrating that the patient has not yet reached a functional plateau and retains rehabilitation potential. 3. Clinical rationale for additional sessions: A letter from the treating therapist or physiatrist explaining why additional sessions beyond the plan's standard limit are medically necessary for this patient, based on the clinical response and remaining deficit. 4. Rehabilitation potential assessment: Documentation that the patient has the cognitive and motor prerequisites to continue benefiting from intensive CIMT. 5. Cigna's quantity-limit policy: Identify the specific limit and whether the policy includes an exception pathway for patients with documented ongoing clinical need. 6. Prior therapy context: If this is a second course of CIMT, document the clinical rationale for re-treatment — such as a new neurological event, a period of functional decline, or new evidence supporting a second course.
## Criteria-Mapping Structure
| Cigna Quantity-Limit Criterion | Supporting Documentation | |---|---| | Sessions within standard program limit | Explain clinical deviation and individual justification | | Ongoing rehabilitation potential | Standardized assessment showing no plateau; therapist evaluation | | Measurable functional improvement | Progress notes with objective functional measures | | Additional sessions medically necessary | Prescriber/therapist letter with clinical rationale | | Exception criteria met (if applicable) | Address each exception criterion in Cigna's policy |
Quantity-limit appeals succeed when they are individualized: the argument is not that the limit is wrong in general, but that this patient's specific clinical trajectory requires more treatment than the standard limit provides.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →